Cheng-I Hsieh, MD PhD

Hematology and Oncology

SPECIALTY/PRACTICE AREAS：
• Chemotherapy on hematology and solid neoplasms
• Hematopoietic disorders
• Coagulation disorders
• Clinical trials
LANGUAGES SPOKEN：
• English
• Chinese

 

PROFESSIONAL EDUCATION：

• Department of pharmacy, Kaohsiung medical college, Kaohsiung, Taiwan (1977-1981)
• Department of medicine, National Cheng Kung University Medical College, Tainan, Taiwan (1984-1989)
• Master of Public Policy and Management, School of Public Policy and Development, University of Southern California(USC) (2004-2005)
• Master of Health Services, School of Public Health, University of California, Los Angeles (UCLA) (2005-2006 )
• Doctoral student, Institute of Health Care Organization Administration, College of Public Health, National Taiwan University (2007-2016)

 

ADMINSTRATIVE APPOINTMENTS：

• Chief Executive Officer, Der-Tao Cancer Care Foundation, Taiwan (1996-2001 )
• Chairman, Hope Society for Cancer Treatment, Taiwan (2002-2004 )
• Attending physician, Division of Hematology/Oncology, Department of Internal Medicine, Taipei Medical University affiliated hospital (Present)

 

PUBLICATIONS：

• Cheng-I Hsieh, Nei-Min Chu, Tran-Der Tam, Hsin-Hsuan Chen, Cheng, Skye Hongiun, Tsai, Stella Y.C., James Jermin Jin, Kai-Cheng Lawrence Yen, Ching-Yuan Lin Huang, Andrew T., Weekly 5-FU and Leucovorin as Maintenance Chemotherapy after CCRT for Advanced Stage (stage IVA, B) Nasopharyngeal Carcinoma; A preliminary Report. The 4th International UICC Symposium on Nasopharyngeal Carcinoma, 2003